- Home
- RNXT vs PAVS Comparison
RNXT vs PAVS Comparison
Compare RNXT & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- PAVS
- Stock Information
- Founded
- RNXT 2012
- PAVS 2004
- Country
- RNXT United States
- PAVS United States
- Employees
- RNXT N/A
- PAVS N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- PAVS Medicinal Chemicals and Botanical Products
- Sector
- RNXT Health Care
- PAVS Health Care
- Exchange
- RNXT Nasdaq
- PAVS Nasdaq
- Market Cap
- RNXT 44.6M
- PAVS 51.5M
- IPO Year
- RNXT 2021
- PAVS 2019
- Fundamental
- Price
- RNXT $1.25
- PAVS $0.73
- Analyst Decision
- RNXT Strong Buy
- PAVS
- Analyst Count
- RNXT 2
- PAVS 0
- Target Price
- RNXT $7.50
- PAVS N/A
- AVG Volume (30 Days)
- RNXT 339.0K
- PAVS 118.5K
- Earning Date
- RNXT 08-14-2025
- PAVS 08-04-2025
- Dividend Yield
- RNXT N/A
- PAVS N/A
- EPS Growth
- RNXT N/A
- PAVS N/A
- EPS
- RNXT N/A
- PAVS N/A
- Revenue
- RNXT $662,000.00
- PAVS $71,542.00
- Revenue This Year
- RNXT $2,988.37
- PAVS N/A
- Revenue Next Year
- RNXT $300.60
- PAVS N/A
- P/E Ratio
- RNXT N/A
- PAVS N/A
- Revenue Growth
- RNXT N/A
- PAVS N/A
- 52 Week Low
- RNXT $0.75
- PAVS $0.32
- 52 Week High
- RNXT $1.69
- PAVS $1.50
- Technical
- Relative Strength Index (RSI)
- RNXT 62.94
- PAVS 46.16
- Support Level
- RNXT $0.90
- PAVS $0.66
- Resistance Level
- RNXT $0.95
- PAVS $0.80
- Average True Range (ATR)
- RNXT 0.08
- PAVS 0.04
- MACD
- RNXT 0.03
- PAVS 0.00
- Stochastic Oscillator
- RNXT 86.54
- PAVS 41.19
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.